Ventana Biotech, Inc.
VNTA
Rank in Stocks
#31723
Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the... Ventana Biotech, Inc. is an emerging biotechnology enterprise focused on the lifecycle of drug candidates for personalized medicine, encompassing the identification, assessment, acquisition, development, and eventual commercialization through partnerships of relevant intellectual property. The company's primary therapeutic area is addressing obesity and its associated medical conditions. Notably, Ventana holds proprietary rights to a medicated chewing gum formulation that integrates an extract of hoodia gordonii and 2-hydroxyoleic acid. This unique composition is intended for the management of obesity, hypertension, and various other metabolic disorders. Ventana is actively engaged in developing these appetite-suppressant chewing gums into distinct products: a lower-dosage version aimed at the over-the-counter market, and a higher-dosage variant slated for distribution via pharmacists. The lower-strength product is expected to be retailed in drugstores and health food establishments. Established in 1989, Ventana Biotech, Inc. operates from Butschwil, Switzerland. The company adopted its current name in October 2008, having previously been known as Personalica, Inc.
Share Price
$0.049
Last synced: 2026-11-09
Market Cap
$2.64M
Change (1 day)
0.00%
Change (1 year)
1.87%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Ventana Biotech, Inc. (VNTA)
Category
Financial Services
EPS for Ventana Biotech, Inc. (VNTA)
EPS as of December 2025 TTM: $0.00
According to Ventana Biotech, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Ventana Biotech, Inc. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 300.00% |
| 2025 | 0.00 | 300.00% |
| 2024 | 0.00 | 33.33% |
| 2023 | 0.00 | -111.54% |
| 2021 | 0.00 | 160.00% |
| 2019 | 0.00 | 42.86% |
| 2018 | 0.00 | -95.88% |
| 2009 | $-0.02 | 2,328.57% |
| 2008 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $0.00 | -37.50% |
US
|
|
| $0.38 | 23,650.00% |
US
|
|
| $0.00 | -256.25% |
CN
|
|
| $0.09 | 5,212.50% |
US
|
|
| $-4.91 | -306,975.00% |
US
|
Questions about Ventana Biotech, Inc.'s earnings per share (EPS)
What is Ventana Biotech, Inc.'s earnings per share (EPS)?
Ventana Biotech, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Dec 2025.
What was Ventana Biotech, Inc.'s earnings per share (EPS) in 2025?
In 2025, Ventana Biotech, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Ventana Biotech, Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Ventana Biotech, Inc.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2025 (0.00).
How does Ventana Biotech, Inc.'s earnings per share (EPS) compare with similar companies?
Ventana Biotech, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Worldwide Webb Acquisition Corp., with $0.38.